Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec 19;116(6):1474-1475.
doi: 10.1093/ajcn/nqac248.

The omega-3 index in Alzheimer's disease: Ready for prime time?

Hussein N Yassine  1   2
Affiliations
Editorial

The omega-3 index in Alzheimer's disease: Ready for prime time?

Hussein N Yassine. Am J Clin Nutr. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Leukot Essent Fatty Acids. 2017;121:68–75. - PMC - PubMed
    1. Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette Set al. . Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012;78(9):658–64. - PMC - PubMed
    1. Thomas A, Baillet M, Proust-Lima C, Feart C, Foubert-Samier A, Helmer Cet al. . Blood polyunsaturated omega-3 fatty acids, brain atrophy, cognitive decline, and dementia risk. Alzheimers Dement. [Accessed 2022 Sep 17]. doi:10.1002/alz.12195. - DOI - PubMed
    1. Butler M, Nelson VA, Davila H, Ratner E, Fink HA, Hemmy LSet al. . Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med. 2018;168(1):52–62. - PubMed
    1. Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes Set al. . Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377–89. - PubMed